U.S. Health Care REITs Stock News

Rezolve AI (RZLV) is back in focus after its board outlined plans for a US$300 million share repurchase program linked to a capital reduction, along with new commercial partnerships and leadership changes. See our latest analysis for Rezolve AI. The stock has drawn fresh attention after the US$300 million buyback announcement, a global resale deal with Tata Consultancy Services and peer reviewed validation of its TraceWare technology. The 7 day share price return of 16.52% contrasts with a...

In the past week, analysts have projected that Jabil will report higher third‑quarter earnings per share and revenue year over year when it releases results on June 17, 2026, with growth expected in areas such as Intelligent Infrastructure and Regulated Industries but softness in Connected Living and Digital Commerce. These expectations, alongside a recent quarterly dividend and attention to segment‑level shifts, highlight how investors are weighing Jabil’s earnings power against signs like...

Some Gen Digital Inc. ( NASDAQ:GEN ) shareholders may be a little concerned to see that the Director, Ondrej Vlcek...

Intellia Therapeutics recently reported additional positive results from its Phase 3 HAELO trial of gene-editing therapy lonvo-z for hereditary angioedema at the EAACI 2026 Congress in Istanbul, showing strong reductions in attack rates and high proportions of attack- and therapy-free patients. The company has also begun a rolling biologics license application with the FDA for lonvo-z, signaling that its first potential commercial gene-editing therapy may be moving closer to the market and...

Earlier this week, nVent Electric plc appointed Nitin Jain as Executive Vice President and Chief Strategy Officer and Joe Stark as Executive Vice President and Chief Revenue Officer, both reporting directly to Chair and CEO Beth Wozniak to oversee global strategy, acquisitions, and sales. The move concentrates decision-making over capital deployment and large deals in a tight leadership group, signaling a clear push to align corporate strategy, acquisition activity, and global revenue...

Capital Southwest (CSWC) drew fresh attention after reporting a softer Q1, with revenue growing 10.2% year over year but landing 7% below analyst estimates, alongside new investments, capital raising and dividend declarations. See our latest analysis for Capital Southwest. At a share price of $23.54, Capital Southwest has seen momentum pick up recently, with a 10.1% 90 day share price return and a 26.4% 1 year total shareholder return hinting at improving sentiment despite the softer Q1...

CVS Health stock moves and recent performance With no single headline event driving CVS Health (CVS) today, the stock's recent performance and business profile give you most of the context for thinking about its role in a diversified portfolio. See our latest analysis for CVS Health. The recent 1-day share price return of 1.47% and 7-day return of 6.29% build on a 90-day share price return of 34.44%, while the 1-year total shareholder return of 56.67% points to momentum that has been strong...

Newmont (NEM) has moved back into focus as investors look ahead to an earnings report that is expected to show strong year over year growth in earnings and revenue, supported by solid cash generation and share buybacks. See our latest analysis for Newmont. The stock has recently bounced, with a 1 day share price return of 2.71%, but a 30 day share price return down 8.10% and a 90 day share price return down 9.04%. At the same time, the 1 year total shareholder return of 74.95% and 3 year...

Why Clear Channel Outdoor Holdings is on investors’ radar today Clear Channel Outdoor Holdings (CCO) has drawn investor attention after recent trading reflected modest short term gains, prompting closer scrutiny of how its current valuation lines up with its fundamentals and risk profile. See our latest analysis for Clear Channel Outdoor Holdings. At a share price of $2.41, Clear Channel Outdoor Holdings has seen steady share price momentum, with a 13.68% year to date share price return and a...

Recent commentary on TransDigm Group highlights that its core aircraft components business has delivered strong organic revenue growth, expanding profitability, and robust free cash flow generation, underpinned by high-margin aftermarket sales of mission-critical parts. An interesting nuance is that this operational strength coexists with recent insider share sales, suggesting executives are realizing gains even as external assessments still score the company highly on profitability and...

Recent performance snapshot Mercury Systems (MRCY) has drawn fresh attention after a strong run in the stock, with gains over the past year and multi year period prompting investors to reassess the defense electronics specialist. See our latest analysis for Mercury Systems. The recent move to a share price of $120.30 caps a strong run, with a 30 day share price return of 30.72% and a 1 year total shareholder return of 127.07%, indicating continued momentum rather than a short lived bounce. If...

MACOM Technology Solutions Holdings (MTSI) has drawn fresh attention after unveiling new RF and optical components for satellite communications, including power and low noise amplifiers, at the International Microwave Symposium in Boston. See our latest analysis for MACOM Technology Solutions Holdings. Recent product news has arrived as momentum in the stock has been strong, with a 1-day share price return of 1.36%, a 90-day share price return of 68.89%, and a 1-year total shareholder return...

What Brown & Brown’s recent performance signals for investors Brown & Brown (BRO) has not been in the headlines for a single defining event, but recent share performance and current fundamentals give you several concrete data points to assess the insurance broker’s risk and return profile. The stock closed at US$59.99, with the month return at 6.6% and the past 3 months showing a decline of 13.3%. Over the past year, total return is down 43.2%, while the 3 year total return is down 7.5% and...

Global trade is picking up again, with AI hardware, semiconductors, and advanced electronics right at the center of that shift. For investors, this news event is a cue to look closely at companies that sit along these supply chains, from chip manufacturers to component suppliers and equipment makers. Some stocks could benefit from stronger export trends, inventory rebuilding, and supply chain expansion across Asia, while others may face pressure from policy risks and competition. This article...

Coinbase Global stock snapshot after recent performance Coinbase Global (COIN) has drawn investor attention after a period where the stock is down about 18% over the past month and about 21% over the past 3 months, despite a 3 year total return above 7x. At a recent close of US$159.78 and a market cap of about US$42.1b, the company sits at an interesting point for investors tracking crypto exposed platforms and weighing shorter term share performance against multi year returns. See our latest...

On June 2, 2026, Pebblebrook Hotel Trust amended its Maryland Declaration to allow shareholders to remove trustees without cause, following prior shareholder approval. This governance change, alongside recent insider share purchases amid revised 2026 net income guidance and a US$19.27 million Q1 net loss on US$345.66 million in revenue, has become a focal point for investors reassessing the REIT’s risk–reward profile. We’ll now examine how the expanded right to remove trustees without cause...

The recent 17% drop in CervoMed Inc.'s ( NASDAQ:CRVO ) stock could come as a blow to insiders who purchased US$455.1k...

We wouldn't blame Centene Corporation ( NYSE:CNC ) shareholders if they were a little worried about the fact that...

AST SpaceMobile recently faced sector-wide selling as investors shifted funds toward newly public SpaceX, while also contending with satellite launch delays linked to Blue Origin’s New Glenn rocket and a short seller report questioning its valuation and funding needs. At the same time, AST SpaceMobile secured key milestones, including FCC approval for U.S. direct-to-device service and a first prime U.S. government contract, while preparing to launch three higher-capacity BlueBird satellites...

Recent updates around Manhattan Associates (MANH) focus on its cloud transformation and newer AI products, including Active Agents pilots and an AI-powered Solution Design Studio. These developments come alongside higher 2026 cloud revenue guidance that has caught investor attention. See our latest analysis for Manhattan Associates. Those AI launches and higher 2026 cloud revenue guidance come after a mixed run for the stock, with an 8.83% 1 month share price return, a year to date share...

In recent weeks, Madison Small Cap Fund highlighted Leonardo DRS in its Q1 2026 investor letter after the company delivered better than expected results, helped by its electronic propulsion system on the Columbia-class submarine platform and exposure to the Golden Dome missile defense initiative. At the same time, insider share sales and ongoing benefits from the US Department of War’s move away from larger prime contractors have drawn attention to how Leonardo DRS’s mix of long-term...

Veralto (VLTO) is back in focus after Metir PLC reported its first PFAS detector sale to the company, linking AI-powered data analysis with Veralto’s global water monitoring projects and core Water Quality segment. See our latest analysis for Veralto. Veralto’s latest share price of US$83.36 comes after a 1-day share price return of 0.87%, although the stock is down 15.37% on a year to date share price basis and 13.92% on a 1 year total shareholder return, suggesting recent momentum has...

Stock move puts Martin Marietta Materials in focus Recent trading interest in Martin Marietta Materials (MLM) has drawn attention to how the stock lines up against its fundamentals, including revenue of US$6,350.0m and net income of US$965.0m. See our latest analysis for Martin Marietta Materials. At a share price of US$577.33, Martin Marietta Materials has seen a 2.08% 1 day share price return and a 3.34% 30 day share price return, although the share price is down 9.00% year to date. The 1...

ADMA Biologics (ADMA) is back in focus after multiple law firms announced securities class action lawsuits alleging channel stuffing, undisclosed related party transactions, and weak internal controls, putting the company’s revenue quality and governance under scrutiny. See our latest analysis for ADMA Biologics. The share price has been under pressure for several months, with a 90 day share price return down 48.17% and a year to date share price return down 54.08%. However, the 5 year total...